These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28941122)

  • 1. Evaluation of periostin and factors associated with new bone formation in ankylosing spondylitis: Periostin may be associated with the Wnt pathway.
    Solmaz D; Uslu S; Kozacı D; Karaca N; Bulbul H; Tarhan EF; Ozmen M; Can G; Akar S
    Int J Rheum Dis; 2018 Feb; 21(2):502-509. PubMed ID: 28941122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.
    Sakellariou GT; Anastasilakis AD; Bisbinas I; Oikonomou D; Gerou S; Polyzos SA; Sayegh FE
    Rheumatology (Oxford); 2015 May; 54(5):908-14. PubMed ID: 25349442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
    Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
    J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters.
    Sakellariou GT; Iliopoulos A; Konsta M; Kenanidis E; Potoupnis M; Tsiridis E; Gavana E; Sayegh FE
    Joint Bone Spine; 2017 May; 84(3):309-315. PubMed ID: 27369645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis.
    Sun W; Tian L; Jiang L; Zhang S; Zhou M; Zhu J; Xue J
    Clin Rheumatol; 2019 Apr; 38(4):989-995. PubMed ID: 30443790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.
    Taylan A; Sari I; Akinci B; Bilge S; Kozaci D; Akar S; Colak A; Yalcin H; Gunay N; Akkoc N
    BMC Musculoskelet Disord; 2012 Oct; 13():191. PubMed ID: 23025387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis.
    Heiland GR; Appel H; Poddubnyy D; Zwerina J; Hueber A; Haibel H; Baraliakos X; Listing J; Rudwaleit M; Schett G; Sieper J
    Ann Rheum Dis; 2012 Apr; 71(4):572-4. PubMed ID: 22186710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.
    Korkosz M; Gąsowski J; Leszczyński P; Pawlak-Buś K; Jeka S; Siedlar M; Grodzicki T
    Scand J Rheumatol; 2014; 43(1):43-8. PubMed ID: 24447112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
    Saad CG; Ribeiro AC; Moraes JC; Takayama L; Goncalves CR; Rodrigues MB; de Oliveira RM; Silva CA; Bonfa E; Pereira RM
    Arthritis Res Ther; 2012 Oct; 14(5):R216. PubMed ID: 23062122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between sclerostin level and radiographic changes in patients with ankylosing spondylitis].
    Xie J; Yu X
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1300-4. PubMed ID: 26081658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin and Dkk-1 in patients with ankylosing spondylitis.
    Ustun N; Tok F; Kalyoncu U; Motor S; Yuksel R; Yagiz AE; Guler H; Turhanoglu AD
    Acta Reumatol Port; 2014; 39(2):146-51. PubMed ID: 25111416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
    Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum functional dickkopf-1 levels are inversely correlated with radiographic severity of ankylosing spondylitis.
    Yucong Z; Lu L; Shengfa L; Yongliang Y; Ruguo S; Yikai L
    Clin Lab; 2014; 60(9):1527-31. PubMed ID: 25291949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of dickkopf-1 enhances the proliferation and osteogenic potential of fibroblasts isolated from ankylosing spondylitis patients via the Wnt/β-catenin signaling pathway in vitro.
    Zou YC; Yang XW; Yuan SG; Zhang P; Ye YL; Li YK
    Connect Tissue Res; 2016 May; 57(3):200-11. PubMed ID: 26837533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study.
    Perrotta FM; Ceccarelli F; Barbati C; Colasanti T; De Socio A; Scriffignano S; Alessandri C; Lubrano E
    J Immunol Res; 2018; 2018():9101964. PubMed ID: 29854850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VEGF and BMP-2 levels in patients with ankylosing spondylitis and the relationship to treatment with tumour necrosis factor alpha inhibitors.
    Tošovský M; Bradna P; Andrýs C; Andrýsová K; Cermáková E; Soukup T
    Acta Medica (Hradec Kralove); 2014; 57(2):56-61. PubMed ID: 25257151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic proteins and Dickkopf-1 in ankylosing spondylitis.
    Liao HT; Lin YF; Tsai CY; Chou TC
    Scand J Rheumatol; 2018 Jan; 47(1):56-61. PubMed ID: 28303752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
    Rossini M; Viapiana O; Idolazzi L; Ghellere F; Fracassi E; Troplini S; Povino MR; Kunnathully V; Adami S; Gatti D
    Calcif Tissue Int; 2016 May; 98(5):438-45. PubMed ID: 26645432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.
    Torres L; Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
    Osteoporos Int; 2019 Feb; 30(2):441-449. PubMed ID: 30306221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
    Kim HR; Lee SH; Kim HY
    Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.